XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Earnings
Noncontrolling Interest
Total
Beginning balance at Dec. 26, 2020 $ 61,206 $ 218,224 $ 1,182,680 $ (1,794) $ 22,836 $ 1,483,152
Increase (Decrease) in Stockholders' Equity            
Net earnings     103,311   940 104,251
Foreign currency translation adjustment       (374) (526) (900)
Unrealized gain (loss) on debt securities       (1,296)   (1,296)
Distributions to noncontrolling interest         (2,914) (2,914)
Cash dividends     (9,274)     (9,274)
Issuance of shares under employee stock purchase plan 6 357       363
Net issuance (forfeitures) of shares under stock grant programs 537 3,888 5     4,430
Issuance of shares under deferred compensation plans 89 (89)        
Expense associated with share-based compensation arrangements   2,936       2,936
Accrued expense under deferred compensation plans   5,795       5,795
Ending balance at Mar. 27, 2021 61,838 231,111 1,276,722 (3,464) 20,336 1,586,543
Increase (Decrease) in Stockholders' Equity            
Net earnings     173,382   1,978 175,360
Foreign currency translation adjustment       1,759 720 2,479
Unrealized gain (loss) on debt securities       241   241
Cash dividends     (9,276)     (9,276)
Issuance of shares under employee stock purchase plan 9 564       573
Net issuance (forfeitures) of shares under stock grant programs (6) (224) 5     (225)
Issuance of shares under deferred compensation plans 10 (10)        
Expense associated with share-based compensation arrangements   2,728       2,728
Accrued expense under deferred compensation plans   1,140       1,140
Ending balance at Jun. 26, 2021 61,851 235,309 1,440,833 (1,464) 23,034 1,759,563
Increase (Decrease) in Stockholders' Equity            
Net earnings     121,041   4,706 125,747
Foreign currency translation adjustment       (1,897) (210) (2,107)
Unrealized gain (loss) on debt securities       83   83
Redeemable noncontrolling interest         (822) (822)
Cash dividends     (9,281)     (9,281)
Issuance of shares under employee stock purchase plan 10 573       583
Net issuance (forfeitures) of shares under stock grant programs 17 (115)       (98)
Issuance of shares under deferred compensation plans 10 (10)        
Expense associated with share-based compensation arrangements   2,657       2,657
Accrued expense under deferred compensation plans   1,149       1,149
Ending balance at Sep. 25, 2021 61,888 239,563 1,552,593 (3,278) 26,708 1,877,474
Beginning balance at Dec. 25, 2021 61,902 243,995 1,678,121 (5,405) 37,956 2,016,569
Increase (Decrease) in Stockholders' Equity            
Net earnings     189,703   3,428 193,131
Foreign currency translation adjustment       2,930 949 3,879
Unrealized gain (loss) on debt securities       (695)   (695)
Distributions to noncontrolling interest         (2,053) (2,053)
Cash dividends     (12,541)     (12,541)
Issuance of shares under employee stock purchase plan 10 653       663
Net issuance (forfeitures) of shares under stock grant programs 787 8,959       9,746
Issuance of shares under deferred compensation plans 80 (80)        
Repurchase of shares (45)   (3,499)     (3,544)
Expense associated with share-based compensation arrangements   6,883       6,883
Accrued expense under deferred compensation plans   6,134       6,134
Ending balance at Mar. 26, 2022 62,734 266,544 1,851,784 (3,170) 40,280 2,218,172
Increase (Decrease) in Stockholders' Equity            
Net earnings     203,118   4,735 207,853
Foreign currency translation adjustment       (3,660) (95) (3,755)
Unrealized gain (loss) on debt securities       (628)   (628)
Cash dividends     (15,474)     (15,474)
Issuance of shares under employee stock purchase plan 14 781       795
Net issuance (forfeitures) of shares under stock grant programs 28 1,092       1,120
Issuance of shares under deferred compensation plans 12 (12)        
Repurchase of shares (1,165)   (88,506)     (89,671)
Expense associated with share-based compensation arrangements   5,556       5,556
Accrued expense under deferred compensation plans   1,100       1,100
Ending balance at Jun. 25, 2022 61,623 275,061 1,950,922 (7,458) 44,920 2,325,068
Increase (Decrease) in Stockholders' Equity            
Net earnings     167,241   4,380 171,621
Foreign currency translation adjustment       (3,330) (29) (3,359)
Unrealized gain (loss) on debt securities       (560)   (560)
Distributions to noncontrolling interest         (9,970) (9,970)
Redeemable noncontrolling interest         (7,641) (7,641)
Cash dividends     (15,405)     (15,405)
Issuance of shares under employee stock purchase plan 11 641       652
Net issuance (forfeitures) of shares under stock grant programs (6) (159) 6     (159)
Issuance of shares under deferred compensation plans 10 (10)        
Expense associated with share-based compensation arrangements   7,407       7,407
Accrued expense under deferred compensation plans   1,085       1,085
Ending balance at Sep. 24, 2022 $ 61,638 $ 284,025 $ 2,102,764 $ (11,348) $ 31,660 $ 2,468,739